Table 3.
Univariate survival analysis associated with DFS and OS.
| Variables | DFS | OS | ||
|---|---|---|---|---|
| HR (95%CI) | P value | HR (95%CI) | P value | |
| Gender | ||||
| Female | 1 | 1 | ||
| Male | 0.666 (0.404–1.097) | .11 | 0.597 (0.359–0.993) | .047 |
| Age | ||||
| ≤65 | 1 | 1 | ||
| >65 | 1.043 (0.633–1.719) | 0.868 | 0.966 (0.586–1.594) | 0.893 |
| BMI | ||||
| ≤24 | 1 | 1 | ||
| >24 | 1.106 (0.666–1.838) | 0.696 | 1.054 (0.634–1.752) | 0.839 |
| Tumor site | ||||
| Right colon + transvers colon | 1 | 1 | ||
| Left colon + rectum | 0.717 (0.434–1.185) | 0.194 | 0.804 (0.486–1.331) | 0.397 |
| Protective loop ileostomy | ||||
| No | 1 | 1 | ||
| Yes | 0.779 (0.467–1.298) | 0.338 | 0.786 (0.471–1.311) | 0.357 |
| Pathological stage | ||||
| I + II | 1 | 1 | ||
| III + IV | 6.266 (3.090–12.706) | <0.001 | 4.976 (2.450–10.109) | <0.001 |
| CEA | ||||
| ≤5 | 1 | 1 | ||
| >5 | 1.575 (0.957–2.592) | 0.074 | 1.368 (0.827–2.262) | 0.222 |
| CA19-9 | ||||
| ≤30 | 1 | 1 | ||
| >30 | 1.575 (0.868–2.857) | 0.135 | 1.445 (0.796–2.622) | 0.226 |
| Anastomotic fistula | ||||
| No | 1 | 1 | ||
| Yes | 1.182 (0.710–1.967) | 0.52 | 1.434 (0.822–2.503) | 0.204 |
| Intestinal obstruction | ||||
| No | 1 | |||
| Yes | 1.393 (0.845–2.297) | 0.193 | 1.511 (0.913–2.502) | 0.108 |
| Diabetes | ||||
| No | 1 | 1 | ||
| Yes | 1.106 (0.666–1.838) | 0.696 | 1.054 (0.634–1.752) | 0.839 |
| Hypertension | ||||
| No | 1 | 1 | ||
| Yes | 1.106 (0.666–1.838) | 0.696 | 1.054 (0.634–1.752) | 0.839 |
| NLR | ||||
| ≤3.91 | 1 | 1 | ||
| >3.91 | 1.336 (0.804–2.220) | 0.264 | 1.441 (0.866–2.396) | 0.16 |
| LMR | ||||
| >3.89 | 1 | 1 | ||
| ≤3.89 | 1.495 (0.894–2.500) | 0.125 | 2.185 (1.285–3.717) | 0.004 |
| PLR | ||||
| ≤141.07 | 1 | 1 | ||
| >141.07 | 1.444 (0.846–2.466) | 0.178 | 1.163 (0.677–1.966) | 0.585 |
| WHR | ||||
| ≤4.604 | 1 | 1 | ||
| >4.604 | 4.361 (2.337–8.138) | <0.001 | 5.503 (2.997–10.106) | <0.001 |
| FAR | ||||
| ≤0.086 | 1 | 1 | ||
| >0.086 | 2.532 (1.478–4.336) | 0.001 | 3.832 (2.193–6.696) | <0.001 |